Stockreport

Results from First Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two Months

Kiromic BioPharma, Inc.  (KRBP) 
PDF Second Patient Completed Treatment and Third Patient Dosed in Phase 1 Study Evaluating Deltacel™ for the Treatment of Non-Small Cell Lung Cancer HOUSTON--(BUSINESS WI [Read more]